Ken Griffin
MATN

Ken Griffin’s Mateon Therapeutics, Inc. MATN Stock Holding History

Ken Griffin’s Portfolio MATN Stock Details MATN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-27,950
Closed -$17K – 8318
2016
Q3 		$17K Buy
27,950
+4,917
+21% +$3.33K ﹤0.01% 7101
2016
Q2 		$16K Buy
+23,033
New +$16.3K ﹤0.01% 6682

Other funds holding MATN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Ken Griffin's MATN Position: Q4 2016 in Review

Ken Griffin sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 27,950 shares — an estimated $17K sold.

Ken Griffin first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $17K in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Ken Griffin reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Ken Griffin sold 27,950 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $17K.
  • Ken Griffin first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Ken Griffin's Mateon Therapeutics, Inc. position peaked at $17K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.